We sought to determine the impact the R264C mutation has on cellular proliferation and tumor onset in a melanoma model, since low MITF expression has been shown to be oncogenic in a subset of melanomas17,18 and promotes tumor initiation in cultured melanoma cell lines30. The gene discussed is MITF; the disease is neoplasm.